drugset / Trial / NCT05968846

Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load

NCT05968846 ↗

NaSingle-groupOpen-labelBasic science

Summary

The goal of this research study is to determine whether changes in organ-specific uptake of 124I- AT-01 can be measured by PET/CT imaging and further, whether these values correlate with changes in a subject's disease status and thereby enable monitoring of disease response over time in terms of organ-specific amyloid load.

Timeline

Start
2022-12-07
Primary completion
2023-08-01
Completion
2023-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject IODINE I124 EVUZAMITIDE Diagnostic / imaging agent 74 mbq Intravenous

Indications